Home Retrophin

Retrophin

acquired
Post-IPO Round
Developer of Rare Disease Therapeutics
Basic
Enterprise Profile

Basic Information

Retrophin is a biopharmaceutical company that develops and delivers life-changing therapies for people with rare diseases.
Retrophin, Inc.
SanDiego,California,United States of America
101~500 people
January 01, 2011
info@retrophin.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology
Concept
Disease Treatment Rare Diseases
Application Scenarios
Innovative Drugs